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ABSTRACT
Matrix metalloproteinases (MMPs) are zinc-dependent endopeptidases that degrade 
the extracellular matrix and other extracellular proteins. Upregulation of MMPs activity 
is known to be required for the inflammatory cell infiltration after spinal cord injury 
(SCI) and most likely contributes to early blood spinal barrier disruption and inflam-
mation, thereby leading to the impairment of functional recovery. Here, we examined 
the effect of ethanol extract of Bupleurum falcatum (BF) on functional recovery by 
inhibiting MMP-2 and -9 activation and inflammation after SCI. Rats received a mo-
derate, weight-drop contusion injury to spinal cord were administered orally with BF at 
a dose of 100 mg/kg for 14 d and functional recovery was measured by Basso- 
Beattie-Bresnahan locomotor open field behavioral rating test, inclined plane test and 
foot print analysis. To examine the neuroprotective effect of BF, TUNEL staining and 
counting were also performed. In addition, the expression and/or activation of MMP-2, 
MMP-9 and inflammatory mediators such as TNF-α, IL-1β, COX-2, and iNOS were 
examined by RT-PCR and gelatin zymography using spinal cord tissue from 1 d after 
injury. Our data showed that BF significantly inhibited the expression and activation of 
both MMP-2 and MMP-9 after SCI. The mRNA expressions of TNF-α, IL-1β, COX-2, 
and iNOS were also significantly attenuated by BF. Furthermore, BF reduced apoptotic 
cell death at 1 d after injury, thereby significantly reduced lesion volume and improved 
functional recovery. Taken together, these results suggest that BF can be used as a 
potential therapeutic agent for treating acute spinal injury.
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INTRODUCTION
    Spinal  cord  injury  (SCI)  is  a  leading  cause  of 
permanent disability, resulting in partial or complete 
loss of motor and sensory function below the lesion Recovery  by  Bupleurum  falcatum a f t e r  S C I 147
site  (Wells  et  al.,  2003).  Inflammatory  and  immune 
responses  are  one  of  the  major  factors  exacer-
bating  the  pathogenesis  after  SCI.  It  is  known  that 
blood-brain  barrier  (BBB)  permeability  and  thereby 
blood  infiltration  is  increased  after  SCI.  Infiltrated 
cells  such  as  macrophage  and  neurophil  are  also 
known  to  be  involved  in  inflammation  after  SCI. 
Furthermore,  proteinases  and  in  particular,  matrix 
metalloproteinases  (MMPs),  are  likely  mediators  of 
early  secondary  vascular  pathogenesis  after  SCI 
(Noble  et  al.,  2002;  Bareyre  and  Schwab,  2003). 
    MMPs  are  soluble  and  cell-surface  bound  zinc- 
dependent  endopeptidases  (Birkedal-Hansen  et  al., 
1993)  that  degrade  the  extracellular  matrix  and 
other  extracellular  proteins  (Sternlicht  and  Werb, 
2001).  MMPs  also  play  important  roles  in  re-
modeling  of  the  extracellular  matrix,  tissue  mor-
phogenesis, and wound healing (Werb, 1997). How-
ever, excessive proteolytic activity of MMPs can be 
detrimental,  leading  to  numerous  pathologic  con-
ditions,  including  BBB  disruption  (Rosenberg  et  al., 
1998)  and  inflammation  (Mun-Bryce  and  Rosen-
berg,  1998).  For  example,  MMPs  are  significantly 
upregulated  after  SCI  in  mice,  rat  and  human 
(Noble  et  al.,  2002; Wells  et  al.,  2003;  Buss  et  al., 
2007). Furthermore, MMPs mainly expressed during 
the first weeks after injury are known to be involved 
in  the  destructive  inflammation  events  of  protein 
breakdown  and  phagocytosis  by  infiltrating  neutro-
phils  and  macrophages  and  in  enhanced  per-
meability  of  the  blood  spinal  cord  barrier  (Noble  et 
al.,  2002;  Wells  et  al.,  2003;  Buss  et  al.,  2007).  In 
particular,  the  activities  of  MMP-2  and  MMP-9, 
which  degrade  types  IV  and  V  collagen,  and  thus 
modify  constituents  of  basal  laminae  (Werb,  1997) 
are  known  to  be  increased  within  1  d  after  SCI 
(Noble et al., 2002; Choi et al., 2010). Moreover, it 
was  clearly  demonstrated  that  the  pharmacological 
blockade  of  MMPs,  limited  to  the  first  3  d  after 
injury,  is  neuroprotective  and  promotes  long-term 
recovery  of  hindlimb  function  (Noble  et  al.,  2002). 
However,  this  beneficial  response  is  lost  when 
treatment  is  extended  beyond  the  acutely  injured 
cord  to  include  wound  healing  and  tissue  re-
modeling  (Trivedi  et  al.,  2005;  Hsu  et  al.,  2006). 
These  data  suggest  that  the  attenuation  of  MMP 
activities  in  early  stage  after  SCI  may  exert  be-
neficial  effect  and  improve  functional  recovery. 
    The roots of Bupleurum falcatum have been used 
in  Oriental  countries  as  a  herbal  medicine  for 
treating  hepatitis,  nephritis,  influenza,  inflammation, 
and bacterial and viral infections (Kumazawa et al., 
1990).  The  extract  of  Bupleurum  falcatum ( B F )  
contains  various  compounds  including  a  series  of 
triterpene saponins namely saikosaponins (Ebata et 
al.,  1996).  Previous  reports  showed  that  saikos-
aponins  exhibit  a  variety  of  pharmacological  ac-
tivites  including  anti-inflammatory,  immunomodula-
tory  and  anti-bacterial  activites  in  vitro  and  in  vivo 
(Yamaguchi  et  al.,  1985;  Kumazawa  et  al.,  1990). 
Furthermore,  saikosaponins  have  been  shown  to 
modulate  the  gene  expression  or  activation  of 
MMP-2  in  endothelial  cells  and  spleen  cells  from 
picryl  chloride-induced  ear  contact  sensitivity  mice 
(Shyu  et  al.,  2004;  Zhang  et  al.,  2006).  These 
observations  suggest  that  BF  may  exert  anti-in-
flammatory  effect  by  inhibiting  MMPs  activity.
    In  this  study,  we  showed  that  the  systemic  ad-
ministration  of  BF  significantly  improves  functional 
recovery  after  SCI  in  part  by  inhibiting  the  ex-
pression  and/or  activation  of  MMP-2,  MMP-9  and 
inflammatory  mediators,  thereby  inhibiting  apoptotic 
cell  death  and  reducing  lesion  volume. 
MATERIALS  AND  METHODS 
Spinal  cord  injury
    Adult male Sprague Dawley [Sam:TacN (SD) BR; 
Samtako,  Osan,  Korea]  rats  were  subjected  to  mo-
derate contusion injury (10 g×25 mm) as described 
previously  (Yune  et  al.,  2007).  For  the 
sham-operated  controls,  the  animals  underwent  a 
T10  laminectomy  without  weight-drop  injury.  Sur-
gical  interventions  and  postoperative  animal  care 
were  performed  in  accordance  with  the  Guidelines 
and  Policies  for  Rodent  Survival  Surgery  provided 
by  the  Animal  Care  Committee  of  the  Kyung  Hee 
University. 
Preparation  of  BF 
    The  dried  roots  of  Bupleurum  falcatum  were 
extracted  with 70% ethanol as  described  previously 
(Kim  et  al.,  2001).  The  ethanol  filtrate  was  eva-
porated  in  vacuo,  and  powdered  BF  was  stored  at 
−20
oC  until  use.  By  HPLC  analysis,  BF  contains 
saikosaponin A, B1, B2, B3, B4, C, D, G, H and I.148 Jee  Youn  Lee,  et  al.
Table  1. P r i m e r s  u s e d  i n  t h e  p r e s e n t  s t u d y
Gene Primer Sequence Product  length
MMP-2 Sense 5’-ACCATCGCCCATCATCAAGT-3’ 348  bp
Antisence 5’-CGAGCAAAAGCATCATCCAC-3’
MMP-9 Sense 5’-AAAGGTCGCTCGGATGGTTA-3’ 639  bp
Antisence 5’-AGGATTGTCTACTGGAGTCGA  3’
iNOS Sense 5’-CTCCATGACTCTCAGCACAGAG-3’ 401  bp
Antisence 5’-GCACCGAAGATATCCTCATGAT-3’
COX-2 Sense 5’-CCATGTCAAAACCGTGGTGAATG-3’ 374  bp
Antisence 5’-ATGGGAGTTGGGCAGTCATCAG-3’
TNF-α Sense 5’-CCCAGACCCTCACACTCAGAT-3’ 215  bp
Antisence 5’-TTGTCCCTTGAAGAGAACCTG-3’
IL-1β Sense 5’-GCAGCTACCTATGTCTTGCCCGTG-3’ 289  bp
Antisence 5’-GTCGTTGCTTGTCTCTCCTTGTA-3’
GAPDH Sense 5’-TCCCTCAAGATTGTCAGCAA-3’ 308  bp
Antisence 5’-AGATCCACAACGGATACATT-3’
BF  administration
    Powdered  BF  were  suspended  in  sterile  de-
ionized  water  and  administrated  orally  at  a  dose  of 
(100  mg/kg)  beginning  at  2  h  after  SCI  and  then 
once  a  day  for  14  d.
RNA  isolation  and  RT-PCR
    RNA  isolation using  TRIZOL Reagent  (Invitrogen, 
Carlsbad, CA) and cDNA synthesis were performed 
as  described  previously  (Lee  et  al.,  2010).  The 
primers  used  for  MMP-2,  MMP-9,  iNOS,  COX-2, 
TNF-α,  IL-1β and  GAPDH  were  synthesized  by 
the  Genotech  Corp  (Daejeon,  Korea).  Details  of 
primers  used  for  PCR  in  this  study  are  shown  in 
Table  1.  GAPDH  was  used  as  an  internal  control. 
Experiments  were  repeated  three  times  and  the 
values  obtained  for  the  relative  intensity  were 
subjected  to  statistical  analysis.  The  gels  shown  in 
figures  are  representatives  of  results  from  three 
separate  experiments. 
Gelatin  zymography
    Total protein extracts from spinal cord samples at 
1  d  after  injury  were  prepared  as  described  pre-
viously  (Yune  et  al.,  2007).  Spinal  cord  tissues  (1 
cm)  were  homogenized  in  a  lysis  buffer  and  the 
tissue  homogenates  were  incubated  for  20  min  at 
4
oC, and centrifuged at 25,000×g for 30 min at 4
oC. 
The  protein  level  of  the  supernatant  was  deter-
mined  using  the  BCA  assay  (Pierce,  Rockford,  IL). 
Gelatin  zymography  was  performed  by  using  10% 
zymogram  gel  (Invitrogen)  as  previously  described 
(Choi  et  al.,  2010).  In  brief,  50μg  proteins  were 
mixed  with  sample  buffer  and  loaded  without  boil-
ing.  After  electrophoresis,  the  gel  were  soaked  in 
2.5%  Triton  X-100,  rinsed,  and  incubated  for  24  h 
at  37
oC  in  developing  buffer  (50  mM  Tris-HCl,  pH 
8.5, 0.2 M  N aC l , 5 m M  CaC l 2, 0.02% Brii35). After 
incubation, gels were stained with 0.5% Coomassie 
blue and then destained. Clear bands on the zymo-
gram  were  indicative  of  gelatinase  activity.
Behavioral  tests
    Examination  of  functional  deficits  after  injury  was 
conducted  by  using  the  21-point  Basso-Beattie- 
Bresnahan  (BBB)  locomotion  scale,  inclined  plane 
test  and  foot  print  analysis  as  previously  described 
(Yune  et  al.,  2007). 
Tissue  preparation 
    After  SCI,  spinal  cord  sections  were  prepared  as 
described  previously  (Yune  et  al.,  2007).  In  brief, 
animals  were  perfused  via  cardiac  puncture  with 
4%  paraformaldehyde.  A  20-mm  section  of  the 
spinal  cord,  centered  at  the  lesion  site,  was  dis-
sected  out,  post-fixed  and  placed  in  30%  sucrose. 
The  segment  was  embedded  in  OCT  for  frozen 
sections,  and  longitudinal  or  transverse  sections 
were  then  cut  at  10  or  20μm  on  a  cryostat 
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Fig.  1.  BF  inhibits  the  expression 
and activation of MMP-2 and -9 after 
SCI.  Total  RNA  and  protein  extracts 
from spinal cord samples at 1 d after 
injury were prepared as described in 
the  Methods  section.  (A)  RT-PCR  of 
MMP-2  and  MMP-9  and  (B)  quan-
titative  analysis  (intensity  relative  to 
sham value) of RT-PCR (n=3/group). 
*p＜0.05.  (C)  Gelatine  zymography 
o f  M M P - 2  a n d  M M P - 9 .  ( D )  Q u a n t i -
tative  analysis  (intensity  relative  to 
sham  value)  of  zymography  (n=3/ 
group). Data are presented as means 
±SD  from  three  separate  experi-
ments.  *p＜0.05.
Terminal  deoxynucleotidyl  transferase-mediat-
ed  deoxyuridine  triphosphate-biotin  nick  end 
labeling  (TUNEL)
    One  day  after  injury,  serial  spinal  cord  sections 
(20μm  thickness)  were  collected  and  every  100
μm  section  was  processed  for  TUNEL  as  pre-
viously  described  (Yune  et  al.,  2007).  Only  those 
cells  showing  morphological  features  of  nuclear 
condensation  and/or  compartmentalization  only  in 
the  gray  matter  (GM)  were  counted  as  a  TUNEL- 
positive.  Quantitation  of  TUNEL-positive  cells  was 
accomplished  by  counting  the  number  of  cells 
labeled  positively  as  described  previously  (Yune  et 
al.,  2009). 
Assessment  of  lesion  volume
    Lesion  volume,  using  rats  employed  for  beha-
vioral  analyses,  was  assessed  as  described  pre-
viously  (Yune  et  al.,  2008).  In  brief,  serial  longi-
tudinal  sections  (10μm)  through  the  dorsoventral 
axis  of  the  spinal  cord  were  used  to  determine 
lesion  volume.  Every  50μm,  sections  were  stained 
with  Cresyl  violet  acetate  and  studied  with  light 
microscopy.  Areas  at  each  longitudinal  level  were 
determined,  and  the  total  lesion  volume  derived  by 
means  of  numerical  integration  of  sequential  areas.
Statistical  analysis
    Data  presented  as  the  mean±SD  values.  Com-
parisons  between  vehicle  and  BF  treated  groups 
were made by unpaired Student’s t test. Behavioral 
scores  from  BBB  analysis  and  inclined  plane  tests 
were analyzed by repeated measures ANOVA (time 
vs  treatment).  Tukey’s  multiple  comparison  was 
used  as  Post  hoc  analysis.  Statistical  significance 
was  accepted  with  p＜0.05.  All  statistical  analyses 
were  performed  by  using  SPSS  15.0  (SPSS  Sci-
ence,  Chicago,  IL). 
RESULTS
BF inhibits MMP-2 and MMP-9 expression and 
activation  after  SCI
    It  has  been  known  that  saikosaponins  modulates 
the  gene  expression  or  activation  of  MMP-2  in 
endothelial  cells  and  spleen  cells  from  picryl 
chloride-induced  ear  contact  sensitivity  mice  (Shyu 
et  al.,  2004;  Zhang  et  al.,  2006).  To  test  the 150 Jee  Youn  Lee,  et  al.
Fig.  2. B F  i n h i b i t s  t h e  e x p r e s s i o n  o f  
inflammatory  factors  after  SCI.  (A) 
Total  RNA  isolation  from  spinal  cord 
samples at 1 d after injury were pro-
cessed  as  described  in  the  Method 
section  (n=3/group).  (A)  RT-PCR  for 
TNF-α,  IL-1β,  COX-2  and  iNOS  at 
1  d  after  SCI.  (B)  Quantitative  an-
alysis  shows  that  the  expression  of 
proinflammatory  factors  was  signifi-
cantly reduced by BF treatment. Data 
represent  mean±SD  from  three  se-
parate  experiments.  *p＜0.05.
hypothesis  whether  BF  may  inhibit  MMP-2  and 
MMP-9  activation  after  SCI,  we  first  examined  the 
effect  of  BF  on  the  expression  of  MMP-2  and 
MMP-9 by RT-PCR at 1 d after injury. A basal level 
of MMP-2 expression was detected in sham control. 
A significant upregulation of MMP-2 expression was 
observed  at  1  d  after  SCI  and  BF  treatment 
significantly  reduced  the  MMP-2  mRNA  expression 
(Fig. 1A, B). Similarly, MMP-9 mRNA was markedly 
increased  at  1  d  after  SCI  and  BF  treatment  also 
significantly  attenuated  the  MMP-9  mRNA  expres-
sion (Fig. 1A, B). However, MMP-9 expression was 
not  observed  in  the  sham  control.  Next,  we 
examined  the  enzyme  activities  of  MMP-2  and 
MMP-9  by  gelatin  zymography  using  spinal  cord 
total  extract  from  1  d  after  injury.  As  shown  in 
Figure  1C,  active  form  of  MMP-2  and  MMP-9  was 
strongly induced at 1 d after injury. Pro-MMP-2 and 
pro-MMP-9 were also induced by SCI. Furthermore, 
BF  treatment  significantly  reduced  the  degree  of 
activation of MMP-2 and MMP-9 when compared to 
vehicle-treated  control  (e.g.,  active  MMP-2;  BF 
1.66±0.08  vs  vehicle  3.22±0.22,  p＜0.05/active 
MMP-9; BF 5.3±0.11  vs  vehicle  7.5±0.25, p＜0.05) 
(Fig.  1B,  D).
BF  inhibits  the  expression  of  inflammatory 
mediators  after  SCI 
    It has been known that BBB disruption by MMPs 
including  MMP-2  and  MMP-9  induces  blood  in-
filtration  and  thereby  contributes  to  inflammation 
after  SCI.  Since  BF  reduced  the  expression  and 
activity of MMP-2 and MMP-9 after SCI (Fig. 1), we 
hypothesized  that  BF  would  inhibit  the  expression 
of  inflammatory  factors  after  SCI.  As  shown  in  Fig. 
2A,  TNF-α,  IL-1β,  COX-2  and  iNOS  mRNA  ex-
pression  were  markedly  increased  after  SCI  as 
reported  (Lee  et  al.,  2004;  Yune  et  al.,  2009).  In 
particular,  BF  treatment  significantly  alleviated  the 
expression levels of pro-inflammatory cytokines and 
mediators  when  compared  with  those  of  vehicle- 
treated  control  at  1  d  after  injury  (Fig.  2).
BF  inhibits  apoptotic  cell  death  after  SCI
    Trauma  to  the  spinal  cord  results  in  extensive 
apoptotic  cell  death  (Liu  et  al.,  1997;  Lee  et  al., 
2003). Based on the anti-inflammatory effects of BF 
in  the  injured  spinal  cord  (Fig.  2),  we  hypothesized 
that BF would inhibit apoptotic cell death after SCI. 
Many TUNEL-positive cells were seen mostly within 
the lesion area in the gray matter (GM) at 1 d after 
injury. As shown in Fig. 3, BF treatment significantly 
decreased  the  number  of  TUNEL-positive  cells 
when  compared  to  the  vehicle-  treated  control  (BF 
132±9 vs. Vehicle 205±17 cells, p＜0.05) (Fig. 3B). 
Thus,  our  results  indicate  that  BF  inhibits  apoptotic 
cell  death  after  injury.
BF  improves  functional  recovery  after  SCI
    Previous  report  showed  that  pharmacological 
inhibition  of  MMPs  at  a  early  stage  after  SCI 
improves  locomotor  recovery  (Noble  et  al.,  2002). 
Since  BF  treatment  inhibited  the  expression  and 
activity  of  MMP-2  and  MMP-9  and  also  attenuated 
apoptotic  cell  death  after  injury  (Fig.  1  and  3),  we 
expected that BF would improve functional recovery 
following  injury.  Injured  rats  were  treated  with  BF 
(100 mg/kg) for 14 consecutive days and functional 
recovery  was  then  evaluated  for  35  d  using  the 
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Fig. 3. The effect of BF on apoptotic cell death after SCI. Spinal 
cord  tissues  from  1  d  after  injury  were  processed  for  TUNEL 
staining  as  described  in  the  Method  section  (n=5/group).  (A) 
TUNEL-positive  cells  in  the  GM  at  1  d  after  injury.  Repre-
sentative images were from the sections selected 1 mm rostral to 
the  lesion  epicenter.  Bar,  50μm.  (B)  Quantitative  analysis  of 
TUNEL-positive  cells  in  the  GM  at  1  d  after  injury.  Serial 
transverse  sections  (10μm  thickness)  were  collected  every  100
μm  from  2  mm  rostral  to  2  mm  caudal  to  the  lesion  epicenter 
(total  40  sections  for  neurons).  Data  represent  mean±SD  ob-
tained  from  five  separate  experiments.  *p＜0.05.
analysis.  The  hindlimbs  paralyzed  immediately  after 
injury  were  spontaneously  recovered  within  7  to  14 
d  after  injury  (Fig.  4A)  as  in  previous  report  (Yune 
et  al.,  2007).  The  BBB  scores  were  significantly 
higher  in  rats  treated  with  100  mg/kg  of  BF  by  14 
to 35 d after SCI than in vehicle-treated rats (35 d, 
BF  11.25±0.5  vs  Vehicle  9.0±1.0,  p＜0.05)  (Fig. 
4A).  The  angle  of  incline,  determined  1∼4  weeks 
after  injury,  was  also  significantly  higher  in  BF- 
treated  rats  than  in  vehicle-treated  rats  at  4  weeks 
after  SCI  (4  weeks,  BF  60±2.1  vs  Vehicle  53±2.2, 
p＜0.05)  (Fig.  4B).  Finally,  footprint  analyses  ob-
tained  from  sham-treated,  vehicle-treated  and  BF- 
treated  rats  at  35  d  after  SCI  revealed  that  BF- 
treated  rats  show  more  consistent  forelimb-hindlimb 
coordination  and  less  toe  drag  than  in  vehicle 
control (Fig. 4C). With the 25 mm insult used in the 
present study, the hind paws as well as the central 
pads  of  vehicle-treated  animals  were  not  clearly 
recorded  because  of  the  hindlimb  drags  (Fig.  4C). 
Thus, we didn’t quantify footprint analysis using toe 
spread  and  ipsilateral  distances  (limb  coordination) 
in  this  study. 
BF  reduces  lesion  volume  after  SCI
    The  functional  deficit  after  SCI  is  known  to  be 
correlated  with  the  massive  tissue  loss  (Basso  et 
al., 1996). To examine whether BF preserves spinal 
cord  tissue  after  injury,  we  measured  the  lesion 
volume using rats tested for behavioral analysis. As 
shown  in  Fig.  4D,  BF  treatment  significantly  re-
duced the lesion volume at 38 d after injury than in 
vehicle-treated  rats  (BF  4.2±1.2  mm
3  vs  Vehicle 
8.5±0.7  mm
3,  p＜0.05). 
DISCUSSION
    In  this  study,  we  demonstrated  the  first  time  that 
after  moderate  contusion  injury  to  the  rat  spinal 
cord,  BF  treatment  improved  functional  recovery  by 
inhibiting  the  expression  and/or  activation  MMP-2, 
MMP-9  and  inflammatory  mediators,  thereby  atte-
nuating  apoptotic  cell  death. 
    A  critical  finding  in  this  study  is  that  BF  can 
effectively  inhibit  MMP  upregulation,  thereby  im-
prove  locomotor  function  after  SCI.  The  functional 
impairment after SCI may be attributed to the early 
involvement  of  MMPs  in  secondary  pathogenesis 
after  injury.  It  has  been  known  that  in  brain  and 
injured  spinal  cord,  MMPs  including  MMP-2  and 
MMP-9,  contribute  to  early  secondary  pathogenesis 
by  disrupting  the  BBB  and  promoting  inflammation 
(Rosenberg  et  al.,  1998;  Noble  et  al.,  2002),  oxi-
dative  stress  (Gasche  et  al.,  2001)  and  demye-
lination (Asahi et al., 2001). It was also known that 
animals  treated  with  an  MMP  inhibitor  within  the 
first  3  d  after  injury  showed  less  disruption  of  the 
BBB,  attenuation  of  neutrophil  infiltration,  and  sig-
nificant  locomotor  recovery  compared  with  vehicle- 
treated  control  (Noble  et  al.,  2002).  Our  data 
indicate  that  BF  treatment  significantly  inhibited  the 
expression  and  activity  of  MMP-2  and  MMP-9  after 
SCI  (Fig.  1).  Also,  the  expression  of  inflammatory 
mediators  such  as  TNF-α,  IL-1β,  COX-2  and 152 Jee  Youn  Lee,  et  al.
Fig.  4.  BF  improves  functional  re-
covery  and  reduces  lesion  volume 
after  SCI.  After  SCI,  BF  was  ad-
ministered  orally  at  a  dose  of  100 
mg/kg  beginning  at  2  h  after  SCI 
and  then  once  a  day  for  14  d. 
Functional  recovery  was  assessed 
by  BBB,  inclined  plane  test  and 
footprint  analysis  (n=10/group).  (A) 
BBB  scores.  (B)  Inclined  plane  test. 
Note  that  BF  treatment  significantly 
increased  BBB  score  and  angle  of 
incline  after  SCI.  Data  represent 
mean±SD.  *p＜0.05.  (C)  Representa-
tive  footprints  obtained  from  each 
group  at  35  d  after  SCI.  (D)  Quan-
titative  analysis  of  lesion  volumes  at 
38  d  after  injury  (n=5/group).  Data 
are  presented  as  means±SD  from 
five  separate  experiments.  *p＜0.05.
iNOS was significantly decreased following BF treat-
ment  (Fig.  2).  In  addition,  the  number  of  TUNEL- 
positive  cells  in  the  GM  at  1  d  and  the  lesion 
volume  at  35  d  after  injury  was  significantly 
inhibited  by  BF  treatment  (Fig.  3,  4).  Thus,  these 
results  suggest  that  the  effect  of  neuroprotection 
followed  functional  recovery  by  BF  are  likely 
mediated  in  part  by  inhibiting  MMP-2  and  MMP-9, 
then  attenuating  the  increase  of  BBB  permeability 
and blood infiltration after SCI. However, we did not 
examine  whether  BF  inhibits  BBB  disruption  and 
blood  infiltration  after  injury  in  this  study.  Further 
study  may  be  required  to  elucidate  the  effects  of 
BF  on  BBB  permeability  and  blood  infiltration  after 
SCI.
    It  has  also  been  known  that  the  beneficial  effect 
of  MMP  inhibition  is  lost  by  long  term  blockade  of 
MMPs  for  the  first  week  after  SCI  (Trivedi  et  al., 
2005).  Hsu  et  al.  (2006)  also  demonstrated  that 
MMP-2  increased  between  7  and  14  d  after  injury, 
was  involved  in  wound  healing  and  tissue  re-
modeling  after  SCI.  In  this  study,  we  observed  the 
inhibition  of  MMP-2  by  BF  at  1  d  after  injury.  In 
addition,  it  was  reported  that  the  general  MMPs 
blocker,  GM6001  treatment  for  first  3  d  after  SCI 
improved  functional  recovery  (Noble  et  al.,  2002). 
Furthermore, when we examine the effect of BF on 
MMP-2  at  7  and  14  d  after  injury,  neither  gene 
expression  nor  gelatinase  activity  of  MMP-2  was 
changed  (data  not  shown).  Therefore  we  believe 
that  the  inhibition  of  MMP-2  and  MMP-9  activity  by 
BF at 1 d after injury may contribute to beneficial to 
functional  recovery.  MMP-12  is  also  known  to  be 
upregulated  at  5  d  and  involved  in  the  dysfunction 
in  BBB  permeability  and  inflammation  after  SCI 
(Wells  et  al.,  2003).  Furthermore,  Wells  et  al. 
(2003)  showed  that  functional  recovery  was  sig-
nificantly  improved  in  MMP-12  null  mice  compared 
with wild-type controls. Therefore, further study may 
be needed to examine the effect of BF on MMP-12 Recovery  by  Bupleurum  falcatum a f t e r  S C I 153
after  SCI. 
    We  examined  the  neuroprotective  effect  of  BF 
after  SCI  using  total  ethanol  extract  in  the  present 
study.  During  the  experiment,  neither  significant 
side  effects  nor  an  increase  in  mortality  by  BF 
treatment  were  observed  (data  not  shown).  As  a 
previous  report  showed  that  aikosaponins,  the 
major  components  in  the  roots  of  Bupleurum 
falcatum,  exhibit  anti-inflammatory,  immunomodula-
tory activites in vitro and in vivo (Yamaguchi et al., 
1985; Kang et al., 2008), further study to find active 
components  exhibiting  MMP  inhibition  and  examine 
their  neuroprotection  after  SCI  will  be  processed. 
    In summary, our results indicate that the inhibition 
of  MMP-2  and  MMP-9  by  BF  may  account  for  in 
part  its  neuroprotective  effect  and  provide  an 
evidence  for  BF  as  a  potential  therapeutic  agent 
after  SCI. 
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